OCT1002 shows promising results in prostate cancer research
31st October 2016
Researchers at Ulster University have published the latest results of a three-year study looking at OCT1002 in combination with hormone therapy in prostate cancer.
The research programme was supported by Prostate Cancer UK through a £213,000 grant from the Movember Foundation and the latest results have been published in the Journal of Clinical Cancer Research
Read the paper.